Remove Data Remove Safety Remove Sleep Remove Therapy
article thumbnail

Cannabinoids May Promote a Good Night’s Sleep, Study Finds

Veriheal

Humans come in all shapes and sizes, but there’s one particular thing that we all have in common—we rely on sleep for optimum health and well-being. Aside from helping to maintain a strong immune system, a consistent sleep pattern can also contribute to weight control, steadier blood sugar, a healthier heart, and enhanced mood.

Sleep 98
article thumbnail

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). These patients also reported improved sleep and general quality of life.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Finding Hope: MMJ’s Impact on Maryland Communities

MMJ Recs

Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies. Research and Innovation: Maryland’s MMJ program encourages research and innovation in the field of cannabis-based therapies, benefiting patients both in the state and nationwide.

article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety. www.igcinc.us

article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids.

article thumbnail

University of Calgary announces chair in psychedelic research

Cannabis Law Report

“The data was showing that psychedelics were providing benefits to people suffering from anxiety, depression, addiction and PTSD. ” Parker helped Courtney book into the stateside clinic offering psychedelic therapy and she received five rounds of intravenous ketamine therapy. .”

Therapy 105
article thumbnail

Sapphire Medical Clinics expands patient access to cheapest medical cannabis fees in UK

Cannabis Law Report

The clinic established the UK Medical Cannabis Registry to offer patients medical cannabis products at a reduced price while collecting and analysing clinical data from real-world evidence “to expand our understanding of medical cannabis in the UK”. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52